Shoulder Innovations (SI) received a 510(k) Premarket Notification for the Inset Reverse Total Shoulder System from the FDA, according to a post to the agency’s website.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SI:
- Strong Market Position and Growth Potential Drive Buy Rating for Shoulder Innovations, Inc.
- Shoulder Innovations Reports Strong Revenue Growth Amid Losses
- Shoulder Innovations reports Q2 EPS ($165.53) vs. ($72.74) last year
- 2 New IPOs on the Street – Morgan Stanley Chooses the Superior Stock to Buy
- Figma initiated, Okta upgraded: Wall Street’s top analyst calls